CareLit · DOI-Nachweis · Aktuelle Neurologie
Persistence of the striatal hypertrophy at the symptomatic stage of genetically determined and idiopathic parkinsonism
DOI 10.1055/s-2006-953164
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK. Lasek, C. Klein, C. Gaser, J. Hagenah, C. Büchel, P. Pramstaller, H.R. Siebner, F. Binkofski
ZeitschriftAktuelle Neurologie
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objectives: An increase in gray matter volume in the striatum has been proposed as a mechanism of presymptomatic compensation in asymptomatic heterozygous Parkin- and PINK1- gene mutation carriers (Binkofski et al., 2004). In the present study we investigated changes of basal ganglia (BG) volumes in symptomatic carriers of Parkin gene mutation and in patients with idiopathic Parkinson's disease (iPD) using voxel-bas…
Zitieren
Zitierempfehlung
K. Lasek, C. Klein, C. Gaser, J. Hagenah, C. Büchel, P. Pramstaller, H.R. Siebner, F. Binkofski (2006) Persistence of the striatal hypertrophy at the symptomatic stage of genetically determined and idiopathic parkinsonism. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2006-953164
Mit CareLit weiterarbeiten